| 摘要 |
<p>The present invention relates to sulfonyl compounds that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.</p> |
| 申请人 |
AMGEN INC. |
发明人 |
ASHTON, KATE;BOURBEAU, MATTHEW, PAUL;HONG, FANG-TSAO;LIU, LONGBIN;NISHIMURA, NOBUKO;NORMAN, MARK, H.;POON, STEVE, F.;STEC, MARKIAN, M.;ST. JEAN, DAVID, J., JR;TAMAYO, NURIA, A.;YANG, KEVIN, C. |
